These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18565458)

  • 21. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy.
    Gabryelska A; Szmyd B; Maschauer EL; Roguski A; Canham R; Morrison I; Białasiewicz P; Riha RL
    Sleep Med; 2020 Jul; 71():48-51. PubMed ID: 32492554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
    Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
    J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
    Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR
    Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurophysiological examinations in narcolepsy].
    Wierzbicka A; Wichniak A; Czasak K; Musińska I; Jakubczyk T; Sek A; Jernajczyk W
    Przegl Lek; 2010; 67(9):726-8. PubMed ID: 21387813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
    Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
    Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.
    Ripley B; Overeem S; Fujiki N; Nevsimalova S; Uchino M; Yesavage J; Di Monte D; Dohi K; Melberg A; Lammers GJ; Nishida Y; Roelandse FW; Hungs M; Mignot E; Nishino S
    Neurology; 2001 Dec; 57(12):2253-8. PubMed ID: 11756606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of narcolepsy: from HLA association to hypocretin deficiency].
    Klein G; Burghaus L; Diederich N
    Fortschr Neurol Psychiatr; 2012 Nov; 80(11):627-34. PubMed ID: 22696207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
    Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
    Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA and hypocretin studies in Korean patients with narcolepsy.
    Hong SC; Leen-Kim ; Park SA; Han JH; Lee SP; Lin L; Okun M; Nishino S; Mignot E
    Sleep; 2002 Jun; 25(4):440-4. PubMed ID: 12071546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.
    Baumann CR; Werth E; Stocker R; Ludwig S; Bassetti CL
    Brain; 2007 Jul; 130(Pt 7):1873-83. PubMed ID: 17584779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
    Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
    Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
    Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
    Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nacrolepsy manifesting initially as cataplexy and sleep paralysis: usefulness of CSF hypocretin-1 examination for early diagnosis].
    Kobayashi Y; Miyamoto M; Miyamoto T; Yamazaki K; Hirata K; Kanbayashi T; Shimizu T
    Rinsho Shinkeigaku; 2002 Mar; 42(3):233-6. PubMed ID: 12474294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocretins (orexins) and sleep-wake disorders.
    Baumann CR; Bassetti CL
    Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.